Works matching IS 00071048 AND DT 2022 AND VI 198 AND IP 2

Results: 31

Anti‐severe acute respiratory syndrome coronavirus‐2 adenoviral‐vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 257, doi. 10.1111/bjh.18245

By:

Petito, Eleonora;
Colonna, Elisabetta;
Falcinelli, Emanuela;
Mezzasoma, Anna Maria;
Cesari, Enrica;
Giglio, Elisa;
Fiordi, Tiziana;
Almerigogna, Fabio;
Villa, Alfredo;
Gresele, Paolo

Publication type:

Article

Outcomes of anti‐programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real‐world analysis.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 401, doi. 10.1111/bjh.18231

By:

Momotow, Jesko;
Bühnen, Ina;
Trautmann‐Grill, Karolin;
Kobbe, Guido;
Hahn, Dennis;
Schroers, Roland;
Heinrich, Bernhard;
Gaska, Tobias;
Forstbauer, Helmut;
Schmidt, Burkhard;
Boger, Regina;
Hüttmann, Andreas;
Heil, Gerhard;
Kraemer, Doris M.;
Krüger, William;
Zeremski, Vanja;
Grobe, Norbert;
Jentsch‐Ullrich, Kathleen;
Griesinger, Frank;
Fuchs, Michael

Publication type:

Article

Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. e28, doi. 10.1111/bjh.18224

By:

De Propris, Maria Stefania;
Musiu, Paolo;
Intoppa, Stefania;
Nardacci, Maria Grazia;
Pucciarini, Alessandra;
Santi, Alessia;
Peragine, Nadia;
Canichella, Martina;
De Luca, Maria Lucia;
D'Elia, Gianna Maria;
Del Giudice, Ilaria;
Pulsoni, Alessandro;
Falini, Brunangelo;
Guarini, Anna;
Martelli, Maurizio;
Tiacci, Enrico;
Foà, Robin

Publication type:

Article

Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. e32, doi. 10.1111/bjh.18228

By:

Dittus, Christopher;
Miller, Jordan A.;
Wehbie, Robert;
Castillo, Jorge J.

Publication type:

Article

Corrigendum.

Published in:: 2022
Publication type:: Correction Notice

Corrigendum.

Published in:: 2022
Publication type:: Correction Notice

Anti‐CD20 therapeutic options in immune‐mediated thrombotic thrombocytopenic purpura.

Published in:: British Journal of Haematology, 2022, v. 198, n. 2, p. 225, doi. 10.1111/bjh.18215
Publication type:: Article

Is 'ABO‐D' really a ready‐made package? Why these parameters should be analysed separately in correlation studies?

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. e26, doi. 10.1111/bjh.18222

By:

Gerard, Christiane;
Maggipinto, Gianni;
Minon, Jean‐Marc

Publication type:

Article

B‐cell lymphoma mimicking relapsing polychondritis.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 222, doi. 10.1111/bjh.18220

By:

Dawudi, Yachar;
Benali, Khadija;
Beydon, Maxime;
Hourseau, Muriel;
Sacre, Karim;
Papo, Thomas

Publication type:

Article

End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 333, doi. 10.1111/bjh.18217

By:

Dixon, Jesse G.;
Dimier, Natalie;
Nielsen, Tina;
Zheng, Jamie;
Marcus, Robert;
Morschhauser, Franck;
Evens, Andrew M.;
Federico, Massimo;
Blum, Kristie A.;
Shi, Qian

Publication type:

Article

A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216

By:

Ravichandran, Sriram;
Mahmood, Shameem;
Wisniowski, Brenden;
Sachchithanantham, Sajitha;
Popat, Rakesh;
Lachmann, Helen;
Rabin, Neil;
Ramasamy, Karthik;
Hawkins, Stephen;
Kyriakou, Charalampia;
Gillmore, Julian;
Yong, Kwee;
Hawkins, Philip;
Jackson, Graham;
Pratt, Guy;
D. Wechalekar, Ashutosh

Publication type:

Article

The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 307, doi. 10.1111/bjh.18214

By:

Fajgenbaum, David C.;
Pierson, Sheila K.;
Kanhai, Karan;
Bagg, Adam;
Alapat, Daisy;
Lim, Megan S.;
Lechowicz, Mary Jo;
Srkalovic, Gordan;
Uldrick, Thomas S.;
van Rhee, Frits

Publication type:

Article

Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 397, doi. 10.1111/bjh.18221

By:

Caughey, Melissa C.;
Derebail, Vimal K.;
Carden, Marcus A.;
Novelli, Enrico M.;
Lutsey, Pamela L.;
Key, Nigel S.;
Kshirsagar, Abhijit V.;
Heiss, Gerardo

Publication type:

Article

Acute haemolysis following COVID‐19 vaccination in a thalassaemic patient with G6PD deficiency.

Published in:: British Journal of Haematology, 2022, v. 198, n. 2, p. 221, doi. 10.1111/bjh.18204
Publication type:: Article

Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: A report of 64 patients.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 298, doi. 10.1111/bjh.18202

By:

Nivet, Thomas;
Baptiste, Amandine;
Belin, Lisa;
Ghillani‐Dalbin, Pascale;
Algrin, Caroline;
Choquet, Sylvain;
Lamy, Thierry;
Morel, Véronique;
Musset, Lucile;
Roos‐Weil, Damien;
Viala, Karine;
Leblond, Véronique;
Baron, Marine

Publication type:

Article

Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 288, doi. 10.1111/bjh.18200

By:

Kumar, Sudhir;
Sharma, Atul;
Malik, Prabhat Singh;
Gogia, Ajay;
Pathak, Neha;
Sahoo, Ranjit Kumar;
Gupta, Ritu;
Prasad, Chandra Prakash;
Kumar, Lalit

Publication type:

Article

Dynamic trends in life expectancy and life years lost over five decades in patients from the SEER database with chronic myeloid leukaemia.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. e23, doi. 10.1111/bjh.18205

By:

Shivarov, Velizar;
Grigorova, Denitsa

Publication type:

Article

Cyclic‐AMP signalling, MYC and hypoxia‐inducible factor 1α intersect to regulate angiogenesis in B‐cell lymphoma.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 349, doi. 10.1111/bjh.18196

By:

Ethiraj, Purushoth;
Sasi, Binu;
Holder, Kenneth N.;
Lin, An‐Ping;
Qiu, Zhijun;
Jaafar, Carine;
Elkhalili, Alia;
Desai, Parth;
Saksena, Annapurna;
Ritter, Jacob P.;
Aguiar, Ricardo C. T.

Publication type:

Article

Multiple myeloma treatment – should be continued or not?

Published in:: British Journal of Haematology, 2022, v. 198, n. 2, p. 223, doi. 10.1111/bjh.18212
Publication type:: Article

Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 360, doi. 10.1111/bjh.18208

By:

Taniguchi, Takahide;
Nakayama, Shoko;
Tanaka, Hirokazu;
Rai, Shinya;
Hirase, Chikara;
Morita, Yasuyoshi;
Tatsumi, Yoichi;
Ashida, Takashi;
Matsuda, Mitsuhiro;
Hashimoto, Shigeo;
Matsumura, Itaru

Publication type:

Article

Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 317, doi. 10.1111/bjh.18207

By:

Harrison, Claire N.;
Schaap, Nicolaas;
Vannucchi, Alessandro M.;
Kiladjian, Jean‐Jacques;
Passamonti, Francesco;
Zweegman, Sonja;
Talpaz, Moshe;
Verstovsek, Srdan;
Rose, Shelonitda;
Zhang, Jun;
Sy, Oumar;
Mesa, Ruben A.

Publication type:

Article

How I treat triple‐class refractory multiple myeloma.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 244, doi. 10.1111/bjh.18185

By:

Costa, Luciano J.;
Hungria, Vania;
Mohty, Mohamad;
Mateos, Maria‐Victoria

Publication type:

Article

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 391, doi. 10.1111/bjh.18192

By:

Doyle, Andrew J.;
Stubbs, Matthew J.;
Lester, Will;
Thomas, Will;
Westwood, John‐Paul;
Thomas, Mari;
Percy, Charles;
Prasannan, Nithya;
Scully, Marie

Publication type:

Article

Single‐dose (4.5 mg/m<sup>2</sup>) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 373, doi. 10.1111/bjh.18203

By:

Dhunputh, Chloé;
Strullu, Marion;
Petit, Arnaud;
Merched, Maria;
Pasquet, Marlène;
Azarnoush, Saba;
Leverger, Guy;
Ducassou, Stéphane

Publication type:

Article

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 382, doi. 10.1111/bjh.18188

By:

Early, Macy L.;
Linton, Elizabeth;
Bosch, Allison;
Campbell, Timothy;
Hill‐Briggs, Felicia;
Pecker, Lydia H.;
Lance, Eboni I.;
Lanzkron, Sophie

Publication type:

Article

Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all‐trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 338, doi. 10.1111/bjh.18187

By:

Stengel, Sven;
Petrie, Kevin R.;
Sbirkov, Yordan;
Stanko, Clara;
Ghazvini Zadegan, Faezeh;
Gil, Veronica;
Skopek, Rafał;
Kamiński, Paweł;
Szymański, Łukasz;
Brioli, Annamaria;
Zelent, Arthur;
Schenk, Tino

Publication type:

Article

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 267, doi. 10.1111/bjh.18197

By:

Harrysson, Sara;
Eloranta, Sandra;
Ekberg, Sara;
Enblad, Gunilla;
El‐Galaly, Tarec C.;
Sander, Birgitta;
Sonnevi, Kristina;
Andersson, Per‐Ola;
Jerkeman, Mats;
Smedby, Karin E.

Publication type:

Article

T‐cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single‐centre retrospective analysis of 17 cases.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. e18, doi. 10.1111/bjh.18184

By:

Guo, Jing‐jing;
Cao, Lei;
Zhu, Hua‐yuan;
Miao, Yi;
Du, Xin‐yi;
Wu, Yu‐jie;
Wang, Li;
Xu, Wei;
Li, Jian‐yong;
Fan, Lei

Publication type:

Article

Haematopoietic stem cell gene therapy in inborn errors of metabolism.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 227, doi. 10.1111/bjh.18179

By:

Chiesa, Robert;
Bernardo, Maria Ester

Publication type:

Article

Issue Information.

Published in:: British Journal of Haematology, 2022, v. 198, n. 2, p. 217, doi. 10.1111/bjh.17596
Publication type:: Article

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival.

Published in:

British Journal of Haematology, 2022, v. 198, n. 2, p. 278, doi. 10.1111/bjh.18182

By:

Dávila, Julio;
González‐Calle, Verónica;
Escalante, Fernando;
Cerdá, Seila;
Puig, Noemí;
García‐Sanz, Ramón;
Bárez, Abelardo;
Montes, Carmen;
López, Rosa;
Alonso, José María;
Aguilar, Carlos;
García‐Mateo, Aránzazu;
Labrador, Jorge;
Aguilera, Carmen;
García‐Coca, Alfonso;
Hernández, Roberto;
Mateos, María‐Victoria;
Ocio, Enrique M.

Publication type:

Article